European Notebook: Sanofi, AstraZeneca Seek New Uses For Old R&D Sites
Executive Summary
VCs address the need for new capital at the U.K’s BioTrinity partnering and investor meeting; France and Germany move to work together on translational drug research; and France’s suspension of Bayer’s Diane 35 shows its tougher regulatory line.